Eli Lilly ne India mein launch kiya Alzheimer's ka naya dawa, Lormalzi! Price Dekho, ₹91,688!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Eli Lilly ne India mein launch kiya Alzheimer's ka naya dawa, Lormalzi! Price Dekho, ₹91,688!
Overview

Big news! Eli Lilly ne India mein Alzheimer's ki nayi dawa Donanemab (Lormalzi) launch kar di hai, jiska price ₹91,688 per vial hai. Desh mein dementia ke badhte cases ke liye ye ek nayi therapy hai, lekin logo tak pahunchne mein diagnosis ek bada challenge hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Nayi Dawa, Naya Umeed, Aur Mehnga Price!

So, Eli Lilly ne officially India mein Lormalzi naam se apni Alzheimer's drug Donanemab launch kar di hai. Bhai, ye ek vial ₹91,688 ka hai aur monthly intravenous infusion ke through diya jayega. Ye dawa brain mein jo amyloid plaques hote hain unhein target karti hai, khaas kar un logo ke liye jinhe early stage Alzheimer's hai.

Is launch se US ki ye pharma company India ke growing market mein entry maaregi jahan dementia cases bahut tezi se badh rahe hain.

Winselow Tucker, Jo Eli Lilly India ke President aur General Manager hain, unhone kaha ki Alzheimer's company ke R&D pipeline ka important hissa hai. Unka goal hai ki symptoms treat karne ke bajaye, bimari ki asal vajah par kaam karne wali dawa dein.

Lekin asli game changer toh ye hai ki India mein lagbhag 8.8 million log dementia se suffer kar rahe hain, aur ismein 60-70% cases Alzheimer's ke hain. Aur ye number 2036 tak 19 million cross kar sakta hai! Per problem ye hai ki lagbhag 10 mein se sirf 1 patient ko diagnosis ya treatment mil paati hai. Socha hi nahi tha!

Yehi wajah hai ki advanced therapies jaise Lormalzi tak sabko pahunchana ek bada challenge hoga. Iske liye awareness aur early detection badhana bahut zaroori hai.

Eli Lilly ne pichle 30 saal mein Alzheimer's research par nearly $11 billion kharch kiye hain. Ye log Donanemab jaise disease-modifying agent ko Indian market mein launch karke bada innovation lane ki koshish kar rahe hain. Umeed hai ki blood test jaise naye diagnostic tools early diagnosis ko improve karenge.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.